Expression of verotoxin-1 receptor Gb3 in breast cancer tissue and verotoxin-1 signal transduction to apoptosis

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Johansson, David ^a   Kosovac, Eldina ^a   Moharer, Jasmin ^a   Ljuslinder, Ingrid ^a   Brännström, Thomas ^a   Johansson, Anders ^a   Behnam Motlagh, Parviz ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 9; CERAMIDE GLUCOSYLTRANSFERASE INHIBITOR; DNA FRAGMENT; FLUORESCEIN DIACETATE; GLOBOTRIAOSYLCERAMIDE; JANUS KINASE; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; VEROTOXIN 1; CERAMIDE TRIHEXOSIDE;

AGE DISTRIBUTION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER TISSUE; CELL CYCLE ARREST; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY TEST; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; SIGNAL TRANSDUCTION; SURVIVAL TIME; TUMOR VOLUME; VASCULAR ENDOTHELIUM; ADULT; AGED; BREAST TUMOR; DNA FRAGMENTATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; TUMOR CELL LINE;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA FRAGMENTATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; SHIGA TOXIN 1; SIGNAL TRANSDUCTION; TRIHEXOSYLCERAMIDES;

EID: 62249196067     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-67     Document Type: Article

References (35)

1. Moulder S Hortobagyi GN Advances in the treatment of breast cancer Clin Pharmacol Ther 2008, 83(1):26-36. 18091763
2. Pronzato P Rondini M First line chemotherapy of metastatic breast cancer Ann Oncol 2006, 17(Suppl 5):v165-8. 16807448
3. Kasibhatla S Tseng B Why target apoptosis in cancer treatment? Mol Cancer Ther 2003, 2(6):573-80. 12813137
4. Vaux DL Apoptosis and toxicology-what relevance? Toxicology 2002, 181-182:3-7.
5. Endo Y et al.: Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins Eur J Biochem 1988, 171(1-2):45-50. 3276522
6. Frankel AE Kreitman RJ Sausville EA Targeted toxins Clin Cancer Res 2000, 6(2):326-34. 10690507
7. Gariepy J The use of Shiga-like toxin 1 in cancer therapy Crit Rev Oncol Hematol 2001, 39(1-2):99-106. 11418306
8. LaCasse EC et al.: Shiga-like toxin-1 receptor on human breast cancer, lymphoma, myeloma and absence from CD34(+) hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantation Blood 1999, 94(8):2901-10. 10515895
9. Falguieres T et al.: Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes Mol Biol Cell 2001, 12(8):2453-68. 58606 11514628
10. Larsson R Nygren P A rapid fluorometric method for semiautomated determination of cytotoxicity and cellular proliferation of human tumor cell lines in microculture Anticancer Res 1989, 9(4):1111-9. 2817793
11. Johansson D et al.: Verotoxin-1 induction of apoptosis in Gb3-expressing human glioma cell lines Cancer Biol Ther 2006, 5(9):1211-7. 16929170
12. Johansson D Johansson A Behnam-Motlagh P alpha-Toxin of Staphylococcus aureus overcomes acquired cisplatin-resistance in malignant mesothelioma cells Cancer Lett 2008, 265(1):67-75. 18362050
13. Korzeniewski C Callewaert DM An enzyme-release assay for natural cytotoxicity J Immunol Methods 1983, 64(3):313-20. 6199426
14. Gitig DM Koff A Cdk pathway: Cyclin-dependent kinases and cyclin-dependent kinase inhibitors Mol Biotechnol 2001, 19(2):179-88. 11725487
15. Larsen JK "Washless" procedures for nuclear antigen detection Methods Cell Biol 1994, 41:377-88. 7532266
16. Jimeno A Hidalgo M Blockade of epidermal growth factor receptor (EGFR) activity Crit Rev Oncol Hematol 2005, 53(3):179-92. 15718144
17. Abe A et al.: Improved inhibitors of glucosylceramide synthase J Biochem 1992, 111(2):191-6. 1533217
18. Bold RJ Termuhlen PM McConkey DJ Apoptosis, cancer and cancer therapy Surg Oncol 1997, 6(3):133-42. 9576629
19. Mese H et al.: Regulation of apoptosis reduction in the cisplatin-resistant A431 cell line by Bcl-2 and CPP32 Chemotherapy 2000, 46(1):69-76. 10601800
20. Igney FH Krammer PH Death and anti-death: Tumour resistance to apoptosis Nat Rev Cancer 2002, 2(4):277-88. 12001989
21. Arab S et al.: Verotoxins inhibit the growth of and induce apoptosis in human astrocytoma cells J Neurooncol 1998, 40(2):137-50. 9892096
22. Bhattacharjee RN et al.: Escherichia coli verotoxin 1 mediates apoptosis in human HCT116 colon cancer cells by inducing overexpression of the GADD family of genes and S phase arrest FEBS Lett 2005, 579(29): 6604-10. 16297916
23. Ishitoya S et al.: Verotoxin induces rapid elimination of human renal tumor xenografts in SCID mice J Urol 2004, 171(3):1309-13. 14767339
24. Arab S Rutka J Lingwood C Verotoxin induces apoptosis and the complete, rapid, long-term elimination of human astrocytoma xenografts in nude mice Oncol Res 1999, 11(1):33-9. 10451029
25. Heath-Engel HM Lingwood CA Verotoxin sensitivity of ECV304 cells in vitro and in vivo in a xenograft tumour model: VT1 as a tumour neovascular marker Angiogenesis 2003, 6(2):129-41. 14739619
26. Kovbasnjuk O et al.: The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer Proc Natl Acad Sci USA 2005, 102(52):19087-92. 1323164 16365318
27. Salhia B et al.: The treatment of malignant meningioma with verotoxin Neoplasia 2002, 4(4):304-11. 1531702 12082546
28. Arab S et al.: Expression of the verotoxin receptor glycolipid, globotriaosylceramide, in ovarian hyperplasias Oncol Res 1997, 9(10):553-63. 9507533
29. De Rosa MF et al.: Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog J Biol Chem 2008, 283(8):4501-11. 18003606
30. Lingwood CA Verotoxin/globotriaosyl ceramide recognition: Angiopathy, angiogenesis and antineoplasia Biosci Rep 1999, 19(5):345-54. 10763802
31. Hughes AK et al.: Molecular basis for high renal cell sensitivity to the cytotoxic effects of shigatoxin-1: Upregulation of globotriaosylceramide expression J Am Soc Nephrol 2002, 13(9):2239-45. 12191968
32. Murray LJ et al.: Expression of Burkitt lymphoma-associated antigen (defined by the monoclonal antibody 38.13) on both normal and malignant germinal-centre B cells Int J Cancer 1985, 36(5):561-5. 3877000
33. Arab S Lingwood CA Intracellular targeting of the endoplasmic reticulum/ nuclear envelope by retrograde transport may determine cell hypersensitivity to verotoxin via globotriaosyl ceramide fatty acid isoform traffic J Cell Physiol 1998, 177(4):646-60. 10092217
34. Pearson G et al.: Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions Endocr Rev 2001, 22(2):153-83. 11294822
35. Jia J et al.: C-Jun NH2-terminal kinase-mediated signaling is essential for Pseudomonas aeruginosa ExoS-induced apoptosis Infect Immun 2003, 71(6):3361-70. 155783 12761120